BEAM
Price
$27.36
Change
-$0.15 (-0.55%)
Updated
Dec 12 closing price
Capitalization
2.78B
80 days until earnings call
Intraday BUY SELL Signals
PHVS
Price
$24.16
Change
+$0.18 (+0.75%)
Updated
Dec 12 closing price
Capitalization
1.57B
122 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BEAM vs PHVS

Header iconBEAM vs PHVS Comparison
Open Charts BEAM vs PHVSBanner chart's image
Beam Therapeutics
Price$27.36
Change-$0.15 (-0.55%)
Volume$1.56M
Capitalization2.78B
Pharvaris
Price$24.16
Change+$0.18 (+0.75%)
Volume$367.44K
Capitalization1.57B
BEAM vs PHVS Comparison Chart in %
View a ticker or compare two or three
VS
BEAM vs. PHVS commentary
Dec 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a StrongBuy and PHVS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 14, 2025
Stock price -- (BEAM: $27.51 vs. PHVS: $23.98)
Brand notoriety: BEAM and PHVS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 60% vs. PHVS: 64%
Market capitalization -- BEAM: $2.78B vs. PHVS: $1.57B
BEAM [@Biotechnology] is valued at $2.78B. PHVS’s [@Biotechnology] market capitalization is $1.57B. The market cap for tickers in the [@Biotechnology] industry ranges from $114.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whilePHVS’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • PHVS’s FA Score: 1 green, 4 red.
According to our system of comparison, both BEAM and PHVS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 5 TA indicator(s) are bullish while PHVS’s TA Score has 5 bullish TA indicator(s).

  • BEAM’s TA Score: 5 bullish, 5 bearish.
  • PHVS’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both BEAM and PHVS are a good buy in the short-term.

Price Growth

BEAM (@Biotechnology) experienced а -4.84% price change this week, while PHVS (@Biotechnology) price change was -13.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.68%. For the same industry, the average monthly price growth was +4.10%, and the average quarterly price growth was +64.61%.

Reported Earning Dates

BEAM is expected to report earnings on Mar 03, 2026.

PHVS is expected to report earnings on Apr 14, 2026.

Industries' Descriptions

@Biotechnology (+0.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.78B) has a higher market cap than PHVS($1.57B). PHVS YTD gains are higher at: 25.091 vs. BEAM (10.927). PHVS has higher annual earnings (EBITDA): -166.91M vs. BEAM (-434.55M). BEAM has more cash in the bank: 1.08B vs. PHVS (329M). PHVS has less debt than BEAM: PHVS (579K) vs BEAM (151M). BEAM has higher revenues than PHVS: BEAM (55.7M) vs PHVS (0).
BEAMPHVSBEAM / PHVS
Capitalization2.78B1.57B177%
EBITDA-434.55M-166.91M260%
Gain YTD10.92725.09144%
P/E RatioN/AN/A-
Revenue55.7M0-
Total Cash1.08B329M327%
Total Debt151M579K26,079%
FUNDAMENTALS RATINGS
BEAM: Fundamental Ratings
BEAM
OUTLOOK RATING
1..100
17
VALUATION
overvalued / fair valued / undervalued
1..100
32
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
39
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMPHVS
RSI
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
79%
MACD
ODDS (%)
Bullish Trend 3 days ago
75%
Bearish Trend 3 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
82%
Advances
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 16 days ago
77%
Declines
ODDS (%)
Bearish Trend 24 days ago
84%
Bearish Trend 4 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
77%
Bearish Trend 3 days ago
78%
Aroon
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 3 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signal:
Gain/Loss:
PHVS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HGXIX16.930.16
+0.95%
Hartford Global Impact I
WWSYX21.060.18
+0.86%
Westwood Quality SmallCap Fund Ultra
MADVX20.840.16
+0.77%
BlackRock Equity Dividend Instl
VALAX29.770.16
+0.54%
Al Frank Adv
TIOVX17.78-0.03
-0.17%
Nuveen International Opps W

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
+0.40%
CRSP - BEAM
70%
Closely correlated
+0.87%
RXRX - BEAM
61%
Loosely correlated
-3.98%
NTLA - BEAM
61%
Loosely correlated
+1.92%
PRME - BEAM
59%
Loosely correlated
-1.39%
AXON - BEAM
57%
Loosely correlated
+2.22%
More

PHVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHVS has been loosely correlated with INKT. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if PHVS jumps, then INKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHVS
1D Price
Change %
PHVS100%
+1.27%
INKT - PHVS
34%
Loosely correlated
-1.49%
MGTX - PHVS
34%
Loosely correlated
+3.93%
NUVL - PHVS
34%
Loosely correlated
+0.16%
BEAM - PHVS
33%
Poorly correlated
+0.40%
ANIX - PHVS
33%
Poorly correlated
-6.43%
More